Roche erweitert das Portfolio für die Transplantationsmedizin
Ab sofort bringt Roche die Tests cobas EBV und cobas BKV auf den Mittel- und Hochdurchsatzsystemen cobas 6800 und cobas…
Ab sofort bringt Roche die Tests cobas EBV und cobas BKV auf den Mittel- und Hochdurchsatzsystemen cobas 6800 und cobas…
Today Roche announced that the Canadian Health Authority has accepted the use of its PCR based mycoplasma detection test…
Roche (SIX: RO, ROG; OTCQX: RHHBY) and BioLamina, Stockholm, Sweden today announced the signing of a research and develo…
The Red Cross Blood Transfusion Service of Upper Austria has become the first laboratory in Europe to receive accreditat…
Today Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the use of its PCR based mycoplasma…
Wissenschaftler des University Medical Center Utrecht in den Niederlanden und der Abteilung Bioscience der Forschungsabt…
In an effort to improve preclinical cardiotoxicity assays, reduce drug testing attrition rates, and ensure drug safety,…
Cardiac toxicity is a major concern in drug development and it is imperative that clinical candidates are thoroughly tes…
Cardiotoxicity, which results when drugs adversely affect the heart, explains why roughly one third of new pharmaceutica…
The xCELLigence RTCA System of Roche (SIX: RO, ROG; OTCQX: RHHBY) is being used in the European Union's DETECTIVE ("Dete…